KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Sep 16, 2025 - 3:59PM >>  ABB India 5351.2  [ 0.23% ]  ACC 1865.35  [ 0.28% ]  Ambuja Cements 573.1  [ 0.67% ]  Asian Paints Ltd. 2480.5  [ -0.87% ]  Axis Bank Ltd. 1121.2  [ 1.53% ]  Bajaj Auto 9074.2  [ 0.53% ]  Bank of Baroda 240.6  [ 0.67% ]  Bharti Airtel 1939.85  [ 1.85% ]  Bharat Heavy Ele 232.1  [ 1.13% ]  Bharat Petroleum 318.25  [ -0.02% ]  Britannia Ind. 6218  [ 0.09% ]  Cipla 1556.15  [ 0.53% ]  Coal India 396  [ 0.34% ]  Colgate Palm. 2354.75  [ -0.48% ]  Dabur India 535.25  [ -1.12% ]  DLF Ltd. 786.55  [ 1.41% ]  Dr. Reddy's Labs 1310.55  [ 0.75% ]  GAIL (India) 182.15  [ 1.19% ]  Grasim Inds. 2841.6  [ 1.38% ]  HCL Technologies 1484.2  [ 1.24% ]  HDFC Bank 966.95  [ 0.03% ]  Hero MotoCorp 5308.65  [ 0.36% ]  Hindustan Unilever L 2582.05  [ 0.09% ]  Hindalco Indus. 755.45  [ 0.28% ]  ICICI Bank 1421.75  [ 0.16% ]  Indian Hotels Co 778.6  [ -1.57% ]  IndusInd Bank 742.1  [ 0.31% ]  Infosys L 1511.35  [ 0.22% ]  ITC Ltd. 413.15  [ 0.12% ]  Jindal Steel 1052  [ 0.54% ]  Kotak Mahindra Bank 2021.4  [ 2.55% ]  L&T 3667.15  [ 2.28% ]  Lupin Ltd. 2051.15  [ 0.21% ]  Mahi. & Mahi 3607.55  [ 2.22% ]  Maruti Suzuki India 15566.95  [ 1.99% ]  MTNL 44.98  [ 0.20% ]  Nestle India 1203.45  [ -0.70% ]  NIIT Ltd. 112.1  [ 0.58% ]  NMDC Ltd. 75.45  [ -0.07% ]  NTPC 335.1  [ 1.16% ]  ONGC 235.15  [ 1.25% ]  Punj. NationlBak 108.4  [ -0.05% ]  Power Grid Corpo 288.35  [ 0.68% ]  Reliance Inds. 1405.15  [ 0.42% ]  SBI 831.8  [ 0.84% ]  Vedanta 461.35  [ 1.54% ]  Shipping Corpn. 218.7  [ 1.72% ]  Sun Pharma. 1610.85  [ 0.53% ]  Tata Chemicals 982.5  [ 0.68% ]  Tata Consumer Produc 1096  [ -0.50% ]  Tata Motors 713.65  [ 0.13% ]  Tata Steel 172  [ 1.65% ]  Tata Power Co. 396.05  [ 2.10% ]  Tata Consultancy 3145.45  [ 1.09% ]  Tech Mahindra 1531.5  [ 0.78% ]  UltraTech Cement 12588.4  [ 1.28% ]  United Spirits 1330  [ 1.14% ]  Wipro 253.9  [ 1.07% ]  Zee Entertainment En 115.5  [ 0.39% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

NEULAND LABORATORIES LTD.

16 September 2025 | 03:58

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE794A01010 BSE Code / NSE Code 524558 / NEULANDLAB Book Value (Rs.) 1,087.42 Face Value 10.00
Bookclosure 18/07/2025 52Week High 18100 EPS 202.74 P/E 80.01
Market Cap. 20811.36 Cr. 52Week Low 10191 P/BV / Div Yield (%) 14.92 / 0.07 Market Lot 1.00
Security Type Other

NOTES TO ACCOUNTS

You can view the entire text of Notes to accounts of the company for the latest year
Year End :2025-03 

ii. Rights, preferences and restrictions attached to equity shares

The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to approval of shareholders in the ensuing Annual General Meeting, except in case of interim dividend. In the event of

liquidation of the Company, the holders of equity shares will be entitled to receive the remaining assets of the Company, after distribution of all preferential amounts in proportion of their shareholding. The Company has only one class of equity shares having a par value of ?10 per share. Each holder of equity shares is entitled to one vote per share.

(b) The above loans are secured by pari-passu first charge on property, plant and equipment (both present and future) and second charge (hypothecation) on the current assets of the Company. The term loans of 1 & 3 from banks are also secured by way of personal guarantees extended by Dr. Davuluri Rama Mohan Rao and Davuluri Sucheth Rao which was released w.e.f October 10, 2023.

(c) Vehicles loans outstanding to the tune of ? 527.71 (March 31, 2024: ? 1,059.97) are secured by hypothecation of specific vehicles against which the loan was availed. These vehicle loans are repayable in instalments ranging from 35 to 59 months from the date of the loan.

(d) All the above loans carry interest in the range of 1.8% to 9.0% per annum as at March 31,2025 (March 31,2024: 1.8% to 8.6% per annum).

Notes:

Gratuity

The Company has a defined benefit funded gratuity plan. Every employee who has completed five years or more of service gets a gratuity on departure at 15 days salary (last drawn salary) for each completed year of service. The Company has subscribed to a group gratuity scheme of Life Insurance Corporation of India (LIC), Kotak Gratuity Group Plan and SBI Life. Under the said policy, the eligible employees are entitled for gratuity upon their resignation or in the event of death in lumpsum after deduction of necessary taxes up to a maximum limit of ?20.

Performance Obligation:

Sale of products: Performance obligation in respect of sale of goods is satisfied when control of the goods is transferred to the customer, generally on delivery of the goods and payment is generally due as per the terms of contract with customers.

Sale of services: The performance obligation in respect of maintenance services is satisfied over a period of time and acceptance of the customer. In respect of these services, payment is generally due upon completion of maintenance period based on time elapsed and acceptance of the customer. In certain non-standard contracts, where the Company provides warranties in service of consumer durable goods, the same is accounted for as a separate performance obligation and a portion of the transaction price is allocated based on its relative standalone prices. The performance obligation for the warranty service is satisfied over a period of time based on time elapsed.

Remaining performance obligations

The aggregate value of transaction price allocated to unsatisfied (or partially satisfied) performance obligations in case of contracts for which revenues are recorded over a period of time is ?211.36 (March 31,2024: ?1,151.93), which is expected to be fully recognised as revenue in the next year. No consideration from contracts with customers is excluded from the amount mentioned above and contract asset relating to partially satisfied performance obligations aggregates to ?105.47 as at March 31, 2025 (March 31, 2024: ?302.04)

(i) Details of CSR expenditure :

As per Section 135 of the Companies Act, 2013, a Company, meeting the applicability threshold, needs to spend at least 2% of its average net profit for the immediately preceding three financial years on corporate social responsibility (CSR)activities. The Company has a CSR committee as per the Act. Our CSR activities are primarily aimed at serving disadvantaged, vulnerable, and marginalized stakeholders from weaker socio-economic backgrounds, in the communities where we operate. In the past year, we have focused on promoting education, skill development, empowering women, promoting health and well-being, providing clean water and sanitation, developing village infrastructure and environment sustainability.

We align our objectives with the Sustainable Development Goals (SDGs). Total expenditure required to be incurred on Corporate Social Responsibility (CSR) activities during the year ended March 31,2025 is ? 491.52 (March 31,2024 is ? 297.29 ). The Company has set off the excess CSR amount of ? 11.68 lakhs spent during the year FY 2023-24 against CSR obligation of FY 2024-25.

31. FAIR VALUE MEASUREMENTS (i) Fair value hierarchy

Financial assets and financial liabilities measured at fair value in the Balance Sheet are grouped into three levels of a fair value hierarchy. The three levels are defined based on the observability of significant inputs to the measurement, as follows:

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.

Level 2: The fair value of financial instruments that are not traded in an active market is determined using valuation techniques which maximise the use of observable market data either directly or indirectly.

Level 3: If one or more of the significant inputs is not based on observable market data, the instrument is included in level 3.

The Company's principal financial liabilities comprise borrowings, trade and other payables. The main purpose of these financial liabilities is to finance the Company's operations. The Company's principal financial assets comprise of loans, trade and other receivables, cash and cash equivalents and other bank balances derived directly from its operations.

(iv) The carrying amounts of trade receivables, trade payables and cash and cash equivalents are considered to be the same as their fair values, due to their short-term nature. Difference between carrying amounts and fair values of bank deposits, other financial assets, other financial liabilities and borrowings subsequently measured at amortised cost is not significant in each of the years presented. For all other amortised cost instruments, carrying value represents the best estimate of fair value.

For financial assets measured at fair values, the carrying amounts are equal to the fair values.

32. FINANCIAL INSTRUMENTS RISK MANAGEMENT

The Company is exposed to various financial risks arising from its operations and the use of financial instruments. The key financial risks include market risk, credit risk and liquidity risk. The Company's risk management policies are established to identify and analyse the risks faced by the Company and seek to, where appropriate, minimize potential impact of the risk and to control and monitor such risks. The Company's risk management is coordinated by the Board of Directors and focuses on securing long term and short term cash flows. The Company does not engage in trading of financial assets for speculative purposes.

The following sections provide details regarding the Company's exposure to the financial risks associated with financial instruments held in the ordinary course of business and the objectives, policies and processes for management of these risks.

A. Market risk:

Market risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises two types of risk: interest rate risk and currency risk. Financial instruments affected by market risk include borrowings, deposits, trade receivables and other financial instruments.

The sensitivity analyses in the following sections relate to the position as at March 31,2025 and March 31,2024. The analysis exclude the impact of movements in market variables on the carrying values of gratuity and other post retirement obligations; provisions; and non-financial assets and liabilities.

i. Interest rate risk:

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company has loan facilities on floating interest rate, which exposes the Company to risk of changes in interest rates. The management monitors the interest rate movement and manages the interest rate risk based on its policies, which include entering into interest rate swaps as considered necessary. The Company's investment in deposits with banks are for short durations and therefore do not expose the Company to significant interest rate risk. Below are the details of exposure to fixed rate and variable rate instruments:

ii. Foreign currency risk:

Foreign currency risk is the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates. The Company's exposure to the risk of change in foreign exchange rates relates primarily to the Company's operating activities (when revenue or expense is denominated in foreign currency) and financing activities (when borrowings are denominated in foreign currency), The foreign currencies in which these transactions are denominated are US Dollars, Euros, Japanese Yen, Great British Pound and Swiss Franc.

Every 0.5% increase/decrease in the interest rate component applicable to the respective borrowings would effect the Company's net profit before tax resulting in an expense/income of ?55.51 and ?21.54 for the year ended March 31,2025 and March 31,2024 respectively.


iii. Equity price risk:

The Company's exposure to equity securities price risk arises from investments held by the Company and classified in the balance sheet as FVTOCI/FVTPL. An increase/(decrease) in fair value of investments by 10% shall impact the Company's equity and total comprehensive income by ?1092.12 (March 31,2024: ?12.79).

B. Credit risk

Credit risk is the risk that a counterparty fails to discharge an obligation to the Company, leading to a financial loss. The Company is mainly exposed to the risk of its balances with the bankers and trade and other receivables. None of the Company's cash equivalents, other bank balances, loans and security deposits were past due or impaired as at March 31, 2025 and March 31, 2024.

33. CAPITAL RISK MANAGEMENT

The Company's objective when managing capital is to safeguard the Company's ability to continue as a going concern in order to provide returns for shareholders and benefits for stakeholders and to maintain an optimal capital structure to reduce the cost of capital. Hence, the Company may adjust any dividend payments, return capital to shareholders or issue new shares or sell assets to reduce debt. Total capital is the equity as shown in the statement of financial position. Currently, the Company primarily monitors its capital structure on the basis of the following gearing ratio. Management is continuously evolving strategies to optimize the returns and reduce the risks. It includes plans to optimize the financial leverage of the Company.

C. Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due. The Company manages its liquidity risk by ensuring, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risk to the Company's reputation.

Management monitors rolling forecasts of the Company's liquidity position (comprising the undrawn borrowing facilities) and cash and cash equivalents on the basis of expected cash flows.

Maturities of financial liabilities

The tables below analyse the Company's financial liabilities into relevant maturity groupings based on their contractual maturities for all non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows:

36(a) Investment property

Investment property comprises of carrying value of land and building, representing the cost incurred towards development and construction activity at the said land situated at Nanakramguda, Hyderabad, duly allotted by Telangana State Industrial Infrastructure Corporation Limited ("TSIIC") (erstwhile Andhra Pradesh Industrial Infrastructure Corporation Limited).

36(b) During the year, the Company has fully transferred an investment property located in Nanakramguda, Hyderabad, Telangana, through perpetual lease, resulting in total profit of ? 7,640.36 lakhs being the profit is exceptional in nature, it has been disclosed as a separate line item.

37. GOODWILL

Pursuant to the Scheme of Amalgamation and Arrangement ("the Scheme") duly approved by the National Company Law Tribunal, Hyderabad Bench vide their order dated March 21, 2018, Neuland Health Sciences Private Limited ("NHSPL") and Neuland Pharma Research Private Limited ("NPRPL") (together referred to as "Transferor Companies"), were merged with the Company with appointed date of April 01,2016. NHSPL is engaged in the business of conducting research and development of Peptides and NPRPL is in the business of contract research services.

The purchase consideration of ?31,084.99 paid by way of issue of 22,70,635 equity shares of ?10 each [in accordance with the Scheme, 45,90,608 equity shares of ?10 each held by NHSPL in the Company stands cancelled and the Company shall issue 68,61,095 and 148 fully paid-up equity shares of ?10 each to the shareholders of NHSPL and NPRPL respectively] at a premium of ?1,359 per equity share.

Excess of consideration paid over net assets taken over aggregating to ?27,946.10 is recognized as Goodwill.

The recoverable amount of the above cash generating unit ("CGU") has been assessed using a value-in-use model. The recoverable value is computed based on the net present value of the projected post-tax cash flows plus a terminal value of the cash generating unit to which the goodwill is allocated. Initially a post-tax discount rate is applied to calculate the net present value of the post-tax cash flows. The cash flow projections include specific estimates for five years developed using internal forecasts and a terminal growth rate thereafter of 5%. The planning horizon reflects the assumptions for short-to-mid term market developments which are based on key assumptions such as margins, expected growth rates based on past experience, new product launches and management's expectations / extrapolation

of normal increase / steady terminal growth rate. Discount rate reflects the current market assessment of the risks. The discount rate is estimated based on the weighted average cost of capital for the Company. Post-tax discount rates used were 13.57% for the year ended March 31,2025. The management believes that any reasonable possible change in the key assumptions would not cause the aggregate carrying amount to exceed the aggregate recoverable amount of the cash- generating unit.

40. CONTINGENT LIABILITIES AND PENDING LITIGATIONS

As at

March 31, 2025

As at

March 31, 2024

Disputed income tax liabilities

Assessment year 2004-05 - refer note (a) below

693.33

693.33

Other income tax matters

73.78

54.87

Goods and Service Taxes

Assessment year 2017-18 towards availment of transitional input tax credit (GST)

47.95

47.95

Assessment year 2017-18 towards Refund of un-utilised Education & Secondary Higher Education Cess & Krishi Kalyan Cess not transferred in Tran_1

64.38

64.38

ITC availed on Cancelled Dealers:

Assessment year 2017-18

5.30

5.30

Assessment year 2018-19

8.19

-

Other Disputes/Matters

Public litigation against land parcel allotment by APIICL- refer note (b) below

-

1,902.76

CIGSR Order for land parcel at Bonthapally in survey no 490/2- refer note (c) below

0.64

0.64

CIGSR Order for land parcel at Bonthapally in survey no 490/1- refer note (d) below

3.30

3.30

Certain disputes, for unascertained amounts are pending in the Labour Courts, Telangana Since, the chance of appellants succeeding in their claims is less than probable, the Company does not expects any liability in this respect.

Not

ascertainable

Not

ascertainable


(d) Transaction with related parties

In accordance with the applicable provisions of the Income Tax Act, 1961, the Company is required to use certain specified methods in assessing that the transactions with the subsidiaries, are carried at an arm's length price and is also required to maintain prescribed information and documents to support such assessment. The appropriate method to be adopted will depend on the nature of transactions / class of transactions, class of associated persons, functions performed and other factors as prescribed. Based on certain internal analysis carried out, management believes that transactions entered into with the related parties were carried out at arms length prices.

39. COMMITMENTS

Estimated amount of contracts remaining to be executed on capital account and not provided for (net of advances) amounts to ?8,325.51 (March 31,2024: ?5,791.13).

Notes:

(a) The Income tax authorities had re-opened the income tax assessment of the Company for the assessment year 2004-05 later than the periods permitted by the provisions of the Income Tax Act, 1961 and thereby demanded an additional tax amount of ?693.33 on account of disallowance of certain prior period expenditure recognized by the Company in the computation of gross total income for the assessment year then ended. Aggrieved by the order of the Income Tax department, the management had filed an appeal with the higher authorities which had been successfully decided in favour of the Company. The Income Tax department has however filed an appeal with the Hon'ble High Court of Telangana in this regard, which is pending final outcome. However, on the basis of its internal assessment and considering the order of the first level appellate authority, the Company is confident of securing an favourable order from the High Court and accordingly, no adjustments have been made to the standalone financial statements in this regard.

Other Disputes/Matters:

(b) During 2004, the Company was allotted land parcel by the then Andhra Pradesh Industrial Infrastructure Corporation Limited ("APIIC") for setting up a basic research and development center. Subsequently public interest litigation (PIL) was filed challenging allotments made by APIIC as unconstitutional and to cancel the allotments and resume the lands in all cases where the development has not commenced or the substantial progress has not been made as per the terms of allotments and regulations. During the year, the Hon'ble High Court of Telangana, vide its Order, disposed of the PIL, stating that it is not inclined to grant the relief prayed by the petitioners regarding the matter under dispute with respect to several companies including Neuland Laboratories Limited.

(c) Our Company purchased land in Survey No. 490/2 situated at Bonthapally Village, Jinnaram Mandal, Medak District. The Revenue department issued notices to our Company for resumption of the said land on the ground that the same was "assigned land". Our Company has filed an application before the Collector, Medak District for regularization of the said land as per the applicable laws. Our Company also filed a writ petition before the High Court praying for an order not to take any coercive steps. The High Court vide its order dated March 18, 2011 directed the revenue department to not take any coercive steps till the disposal of the representation filed by our Company.

The matter is pending before the Collector, Medak District. The management believes that the outcome will be in favour of the Company and hence no adjustment is made in the financial statements.

(d) During the financial year ended March 31,2008, the Commissioner and Inspector General of Stamps and Registration (CIGSR), Andhra Pradesh has vide it's order dated February 22, 2008 has cancelled the registration of the land parcel owned by the Company situated at Bonthapally pursuant to complaint made by one of the seller. Aggrieved by the aforesaid order the Company has filed a writ petition challenging order of CIGSR with Hon'ble High Court of Telangana (the 'Court') as the Company was not involved during the proceedings. The Court has vide its order dated December 31, 2010 has directed to maintain the status quo with regards to the possession of the property till further orders passed. Proceedings of the case are still pending with the court. The management is confident that orders will be in the favour of the Company, hence no adjustment is deemed necessary to these standalone financial statements.

41. LEASES

The Company has entered into operating leases of office premises and residential bungalow, with no restrictions and are renewable at the option of either of the parties, for a period of 3 years to 10 years. There are no sub leases. The Company applies the short term lease and lease of low value assets recognition exemption for few leases.

1. The aggregate depreciation expense on right-of-use assets of ? 491.56 (March 31, 2024: ? 321.35) is included under depreciation and amortization expense in the Statement of Profit and Loss.

2. Rental expense recorded for short-term and low value leases was ? 77.84 (March 31,2024: ? 33.44) for the year ended March 31, 2025 (Refer Note 28).

3. The Company does not face a significant liquidity risk with regard to its lease liabilities as the current assets are sufficient to meet the obligations related to lease liabilities as and when they fall due.

44. SEGMENT REPORTING

In accordance with Ind AS 108 - 'Operating segments', segment information has been given in the consolidated financial statements of the Company and therefore no separate disclosure on segment information is given in these standalone financial statements.

45. The Code on Social Security 2020 ('the Code') relating to employee benefits, during the employment and postemployment, has received Presidential assent on September 28, 2020. The Code has been published in the Gazette of India. Further, the Ministry of Labour and Employment has released draft rules for the Code on November 13, 2020. However, the effective date from which the changes are applicable is yet to be notified and rules for quantifying the financial impact are also not yet issued.

The Company will assess the impact of the Code and will give appropriate impact in the financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published.

46. The Company has a process whereby periodically all long term contracts (including derivative contracts) are assessed for material foreseeable losses. At the year end, the Company did not have any long-term contracts (including derivative contracts) for which there were any material foreseeable losses.

47. OTHER STATUTORY INFORMATION:

i The Company does not have any Benami property, where any proceeding has been initiated or pending against the company for holding any Benami property.

ii The Company has not been declared wilful defaulter by any bank or financial institution or government or any government authority.

iii The Company does not have any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act, 1956.

iv The Company does not have any charges or satisfaction which is yet to be registered with Registrar of Companies beyond the statutory period.

v The Company has complied with the number of layers prescribed under clause (87) of section 2 of the Act read with the Companies (Restriction on number of Layers) Rules, 2017.

vi The Company has not entered into any scheme of arrangement which has an accounting impact on current or previous financial year.

vii No funds have been advanced or loaned or invested (either from borrowed funds or share premium or any other sources or kind of funds) by the Company to or in any other person(s) or entity(ies), including foreign entities ("Intermediaries”) with the understanding, whether recorded in writing or otherwise, that the Intermediary shall lend or invest in party identified by or on behalf of the Company (Ultimate Beneficiaries).

viii The Company has not received any fund from any party(s) (Funding Party) with the understanding that the Company shall whether, directly or indirectly lend or invest in other persons or entities identified by or on behalf of the Company ("Ultimate Beneficiaries”) or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries.

ix The Company does not have any undisclosed income which is not recorded in the books of account that has been surrendered or disclosed as income during the year (and previous year) in the tax assessments under the Income Tax Act, 1961 (such as, search or survey or any other relevant provisions of the Income Tax Act, 1961.

x The Company has not traded or invested in crypto currency or virtual currency during the current or previous year.

xi The Company has not revalued its property, plant and equipment (including right-of-use assets) and intangible assets during the current year and previous year.

48. The standalone financial statements are approved for issue by the Company's Board of Directors on May 15, 2025.